Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02121041 · ClinicalTrials.gov registry record · NA

Ambulatory vs Office BP Management Usual Care for Diagnosing and Managing Hypertension: A Pilot Study

A NA study of Hypertension, sponsored by Anthony J Viera, MD, MPH.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT02121041: Completed NA study of Hypertension, sponsored by Anthony J Viera, MD, MPH.

NCT02121041 is a NA study of Hypertension that has completed, run by Anthony J Viera, MD, MPH. The registered enrollment target is 28 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02121041, a NA study of Hypertension, has completed, sponsored by Anthony J Viera, MD, MPH.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the effectiveness of ambulatory blood pressure monitoring to usual care (blood pressure measurement in the office) in diagnosing and managing hypertension.

Conditions Studied

Interventions

  • DRUG Losartan
  • DRUG Chlorthalidone
  • DRUG Amlodipine

Study Locations (1)

North Carolina

  • University of North Carolina - Chapel Hill

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2014-05
Est. Completion 2016-07
Phase NA

Sponsor

Anthony J Viera, MD, MPH

1 total trials

What the Registry Record Tells You About NCT02121041

The ClinicalTrials.gov registry entry for NCT02121041 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is Anthony J Viera, MD, MPH, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Losartan is the first listed.

NCT02121041 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02121041 about?

NCT02121041 is a clinical study titled "Ambulatory vs Office BP Management Usual Care for Diagnosing and Managing Hypertension: A Pilot Study". The purpose of this study is to compare the effectiveness of ambulatory blood pressure monitoring to usual care (blood pressure measurement in the office) in diagnosing and managing hypertension.

What is the current status of trial NCT02121041?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2014-05. Estimated completion is 2016-07.

What conditions does trial NCT02121041 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT02121041?

The interventions under investigation include: Losartan (DRUG), Chlorthalidone (DRUG), Amlodipine (DRUG).

Who is sponsoring clinical trial NCT02121041?

This trial is sponsored by Anthony J Viera, MD, MPH, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02121041 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.